Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Salud Mental (30)

2024

  1. Astrocytic GLUT1 reduction paradoxically improves central and peripheral glucose homeostasis

    Science Advances , Vol. 10, Núm. 42

  2. Effect of antipsychotic drugs on group II metabotropic glutamate receptor expression and epigenetic control in postmortem brains of schizophrenia subjects

    Translational Psychiatry, Vol. 14, Núm. 1

  3. Ligand bias and inverse agonism on 5-HT2A receptor-mediated modulation of G protein activity in post-mortem human brain

    British Journal of Pharmacology

2023

  1. Endocannabinoid 2-Arachidonoylglycerol Synthesis and Metabolism at Neuronal Nuclear Matrix Fractions Derived from Adult Rat Brain Cortex

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

2022

  1. Up-regulation of CB1 cannabinoid receptors located at glutamatergic terminals in the medial prefrontal cortex of the obese Zucker rat

    Frontiers in Neuroanatomy, Vol. 16

2021

  1. Correction to: Functional approaches to the study of G-protein-coupled receptors in postmortem brain tissue: [35S]GTPγS binding assays combined with immunoprecipitation (Pharmacological Reports, (2021), 73, 4, (1079-1095), 10.1007/s43440-021-00253-z)

    Pharmacological Reports

  2. Di-aryl guanidinium derivatives: Towards improved α2-Adrenergic affinity and antagonist activity

    European Journal of Medicinal Chemistry, Vol. 209

  3. Differential brain ADRA2A and ADRA2C gene expression and epigenetic regulation in schizophrenia. Effect of antipsychotic drug treatment

    Translational Psychiatry, Vol. 11, Núm. 1

  4. Effects of platelet-rich plasma on cellular populations of the central nervous system: The influence of donor age

    International Journal of Molecular Sciences, Vol. 22, Núm. 4, pp. 1-20

  5. Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1

    Histochemistry and Cell Biology, Vol. 156, Núm. 5, pp. 479-502

  6. Functional approaches to the study of G-protein-coupled receptors in postmortem brain tissue: [35S]GTPγS binding assays combined with immunoprecipitation

    Pharmacological Reports, Vol. 73, Núm. 4, pp. 1079-1095

  7. Lack of the Transient Receptor Potential Vanilloid 1 Shifts Cannabinoid-Dependent Excitatory Synaptic Plasticity in the Dentate Gyrus of the Mouse Brain Hippocampus

    Frontiers in Neuroanatomy, Vol. 15

  8. Opposite alterations of 5­HT2A receptor brain density in subjects with schizophrenia: relevance of radiotracers pharmacological profile

    Translational Psychiatry, Vol. 11, Núm. 1

  9. Subcellular specificity of cannabinoid effects in striatonigral circuits

    Neuron, Vol. 109, Núm. 9, pp. 1513-1526.e11

2020

  1. Structural and functional brain abnormalities in mouse models of lafora disease

    International Journal of Molecular Sciences, Vol. 21, Núm. 20, pp. 1-15

2019

  1. Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: Selective biased agonism via Gαi1-proteins

    European Neuropsychopharmacology, Vol. 29, Núm. 12, pp. 1453-1463

  2. The motivation for exercise over palatable food is dictated by cannabinoid type-1 receptors

    JCI Insight, Vol. 4, Núm. 5

  3. aEEG and neurologic exam findings correlate with hypoxic–ischemic brain damage severity in a piglet survival model

    Pediatric Research, Vol. 85, Núm. 4, pp. 539-545

2018

  1. Selective up-regulation of cannabinoid CB1 receptor coupling to Go-proteins in suicide victims with mood disorders

    Biochemical Pharmacology, Vol. 157, pp. 258-265

  2. Synaptic regulator α-synuclein in dopaminergic fibers is essentially required for the maintenance of subependymal neural stem cells

    Journal of Neuroscience, Vol. 38, Núm. 4, pp. 814-825